Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02791945 · ClinicalTrials.gov registry record · Phase 2
N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI
A Phase 2 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT02791945 is a Phase 2 study that has completed, run by University of California, San Francisco. The registered enrollment target is 30 participants.
The verdict
NCT02791945, a Phase 2 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of the project is to improve the care of Veterans with mild traumatic brain injury (mTBI) and unhealthy alcohol use.
Interventions
- DRUG Placebo
- DRUG N-acetylcysteine
- BEHAVIORAL Medical Management Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02791945
The ClinicalTrials.gov registry entry for NCT02791945 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02791945 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02791945 about?
NCT02791945 is a clinical study titled "N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI". The goal of the project is to improve the care of Veterans with mild traumatic brain injury (mTBI) and unhealthy alcohol use.
What is the current status of trial NCT02791945?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2016-08. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02791945?
The interventions under investigation include: Placebo (DRUG), N-acetylcysteine (DRUG), Medical Management Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02791945?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.